MTOR and Hyperglycemia: mTOR activation is necessary for the tube formation of bone marrow-derived endothelial progenitor cells (EPCs) and human umbilical vein endothelial cells (HUVECs) [126,127], which can be inhibited in hyperglycemia through mTOR suppression.